-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Wednesday's After-Market Session
Share
Listen to the news

Gainers

  • Streamex (NASDAQ:STEX) shares increased by 11.8% to $3.97 during Wednesday's after-market session. The market value of their outstanding shares is at $157.9 million.
  • Anixa Biosciences (NASDAQ:ANIX) shares increased by 9.34% to $3.57. The company's market cap stands at $117.5 million.
  • Profusa (NASDAQ:PFSA) stock rose 6.89% to $0.11. The company's market cap stands at $7.3 million.
  • Telomir Pharmaceuticals (NASDAQ:TELO) shares rose 5.46% to $1.42. The market value of their outstanding shares is at $48.1 million.
  • Scienture Holdings (NASDAQ:SCNX) shares rose 5.36% to $0.53. The market value of their outstanding shares is at $22.3 million.
  • Adagio Medical Holdings (NASDAQ:ADGM) stock rose 4.95% to $1.27. The company's market cap stands at $24.9 million.

Losers

  • cbdMD (AMEX:YCBD) stock fell 4.0% to $2.18 during Wednesday's after-market session. The company's market cap stands at $12.7 million.
  • FibroBiologics (NASDAQ:FBLG) shares fell 3.88% to $0.27. The market value of their outstanding shares is at $18.0 million.
  • NexGel (NASDAQ:NXGL) stock declined by 3.71% to $1.82. The market value of their outstanding shares is at $13.3 million.
  • GRI Bio (NASDAQ:GRI) stock decreased by 3.42% to $0.41. The market value of their outstanding shares is at $2.8 million.
  • IM Cannabis (NASDAQ:IMCC) shares decreased by 3.41% to $1.7. The market value of their outstanding shares is at $9.0 million.
  • Cryo-Cell International (AMEX:CCEL) shares decreased by 3.38% to $3.72. The market value of their outstanding shares is at $30.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending